AT CLINICAL PRESENTATION, patients with acute myeloid leukaemia (AML) frequently have significant pancytopenia, which persists until cytoreduction of leukaemic cells produces remission. In vitro cultures from AML patients on presentation show a lack of detectable normal myeloid colony-forming cells (CFU-C, early myeloid precursor cells) but early return of CFU-C occurs in patients who later achieve remission (Greenberg et al., 1971; Moore et al., , 1974 Senn et al., 1967; Spitzer et al., 1976a Spitzer et al., , b, 1977 . In vitro cultures with glucose-6-phosphatedehydrogenase isozymes (Adamson, 1979; Fiaklow et al., 1979) and cytogenetics suggest that the remission CFU-C are not leukaemic, but normal in origin, though the in vitro response to leukaemic soluble factors may be abnormal (Broxmeyer et al., 1978a, b, Requests for reprints to: Gary Spitzer 1979). Suppression of normal in vitro progenitor cells is not limited to myeloid progenitor cells, as early progenitor cells committed to erythropoiesis (the burstforming unit erythroids, BFU-E) are reported to be decreased at diagnosis (Fiaklow et al., 1979) . A great deal of research has focused on explaining the suppression of granulopoiesis in myeloid leukaemia, the absence of CFU-C on presentation, and the reappearance of normal CFU-C on remission.
Suppression of normal CFU-C by myeloid leukaemic cells by conditioned media or by extracts has been shown by some (Chiyoda et al., 1975 (Chiyoda et al., , 1976 Craddock et al., 1978; Gordon et al., 1978; Knudtson & Mortenson, 1976; Morris et al., 1975) and not by others (Bull et al., 1973; Greenberg et al., 1971; Robinson et al., 1971) . We report here further experiments to try
Anderson Hospital and Tumor Institute, 6723 Bertner to definie possible interactions between leukaemic cells and normal haemopoiesis. The stimulatory and inhibitory effects that were founcd will be presented and discussed.
MATERIALS AND METHOD)S The acquisition. collection, and preparation of low-density (< 1-077 g/ml) nonadherent normal or leukaemic cells from normal volunteer.s or newly diagnosed leukaemie patients have been described before (Spitzer et al., 1979) . The methods of cloning human inyeloid progenitor cells have also been described in detail (Spitzer et al., 1977) . Briefly, to measure the effects of leukaemic cells on normal growth, leukaemic cells at varying concentrations wvere placed in a maximum volume of 0-1 ml on the bottom of a 35mm tissue-culture plastic Petri dish. One millilitre overlayer of 0.5% agar, alpha modification of minimal essential media (x-MEM), and 1500 foetal calf serum (FCS) with 0-2 ml of human placental-conditioned media (HPCM) was then layered over the leukaemic cells. Experiments in which the colonystimulating activity (CSA) of leukaemic cells was also assessed did not include HPCM. The low-density, nonadherent cells at a concentration of 105/ml were theni cultured above this underlayer in a mixture of 0-3%/ agar, o-MEM, and 15% FCS. The cultures were scored for colonies (aggregates of >40 cells) and clusters (aggregates of 3-39 cells) after 8 and 14 days of incubation in a fully humidified atmosphere of 500 CO2 and air at 370C.
Cells wNere irradiated with 20 Gy from a 137Cs soiiice at a rate of 1-98 Gy/min. Cultures including indomethacin were prepared by adding a dilution of indomethacin from a stock of 10-2M in distilled water and ethanol. The final concentration of indomethacin was 10-6M. Ethanol at these concentrations or indomethacin at 10-6M had no effect on marrow colony formation. To further confirm that this inhibition was not unique to the leukaemic cells used in the initial experiments, further experiments were performed with other leukaemic-cell underlayers. Table I shows the results of 6 such experiments. In 2 experiments (Expts 1-4) inhibition was produced at only high cell numbers (8 x 106) and in two other experiments (2 and 3) at lower cell numbers of (0.5 x 106). (Kurland et al., 1978) and not a nutritional mechanism. It is interesting to note that mononuclear cells increased the stimulus over that observed with HPCM alone (Fig. 2) ments previously described that showed leukaemic inhibition of CFU-C growth were also performed incorporating 10-6M indomethacin and, unlike the results with normal cells, showed no abolition of marrow suppression. In some experiments there was enhancement of suppression at high cell doses, when indomethacin was included in cultures. One such experiment is shown in Table I . This is being further investigated, but it appears certain that prostaglandin synthesis and release are not the mechanism of inhibition. To determine whether cell division was necessary for this suppression, leukaemic cells were irradiated before culture. There were no single cells or clusters in the underlayers when cultures were scored on Day 7 or 14. Results from these experiments are given in Fig. 3 (same leukaemic sample as Fig. 1 ) and in Table II (1) 71 (4) 105 (2) (5) 116 (2) 16 (1) Media conditioned by varying concentrations of leukaemic cells for 7 days were added at a total volume of 0-2 ml to underlayers of 0-5% agar with optimal amounts of CSA (human placental-conditioned media). (2) 28 (2) 33 (2) 19 (2) 32 (1) Varying amounts of absorbed or unabosrbed HPCM (except for one mixing experiment) were placed in agar underlayers and 105 non-adherent, low-density (< 1-077 g/ml) marrow cells were used as a target in a 0-3% upper layer. Values are the mean of 2 plates. not confined to this batch of HPCM, as similar results occurred with other batches. The enhancement was greater when absorption were continued for 60 min or overnight (Table V) . Contrary to expectations, the possibility that an inhibitor of HPCM activity was absorbed was not borne out. Titrations with both absorbed and unabsorbed HPCM suggested that an inhibitor might be present in both preparations at the same volume of 0 3 ml, and mixing unabsorbed and absorbed HPCM did not suppress colony formation below that obtained with absorbed HPCM alone ( Table V) (Chiyoda et al., 1975; Craddock et al., 1978; Cordon et al., 1978; Knudtson & Mortenson, 1976; Morris et al., 1975 It is unlikely that our results are due to poor culture conditions secondary to consumption of nutrients at higher cell concentrations. Colony size was not affected, a finding that has always been seen with poor culture conditions. Also, normal peripheral-blood mononuclear cells with indomethacin or pure monocytic leukaemic cells capable of releasing CSA did not suppress colony growth. Indomethacin did not abolish this leukaemic suppression, which rules out prostaglandin as the mechanism. This suppression probably required some cell division, for sterilization with radiation abolished it.
We expected that, if such suppression was demonstrable in agar culture, a soluble factor affecting this inhibition should be detected by allowing viable leukaemic cells in varying concentrations to condition media. This idea was supported by Broxmeyer's finding of a socalled luekaemic inhibitory activity (LIA), which can suppress CFU-C and can be detected in leukaemic extracts or leukaemic-conditioned media. Despite many attempts with cells from 4 leukaemic patients, including cells showing inhibition of CFU-C growth in co-culture experiments, we have not been able to detect such an inhibitor in conditioned media. Bull et al. (1973) have suggested that leukaemic cells, in response to HLAdiffering marrow, release inhibitory factors. Though mixtures of normal marrow do not show suppression (Chiyoda et al., 1975; Morris et al., 1975) this does not totally rule out the possibility. Also, using different target cells on the same leukaemic patient underlayers, suppression at high cell doses was within a narrow range, an unusual finding if HLA differences accounted for these results.
In the course of these investigations, other unexpected interactions in leukaemic and normal haematopoiesis were discovered. First, irradiation of leukaemic cells before their incorporation into agar culture frequently enhanced the growth of myeloid CFU-C over growth with HPCM alone. The HPCMs we have are routinely more active than human peripheral mononuclear cells, and probably represent the optimal reproducible system for growth of human myeloid CFU-C (Verma et al., 1980) . Secondly, absorption of HPCM at 4°C improved HPCM activity markedly over that at 37°C. This was not due to removal of inhibitor, and the improvement in activity was not specific to leukaemic absorption. It is conceivable that HPCM could interact with the cell membrane, be altered in biochemical composition, and then come off the cell membrane in a more active form. Absorption at 37°C might be associated with production of proteases, and breakdown of this more active moiety. Irradiated cells in culture may alter HPCM in a similar way, enhancing cell growth. Metabolism may not be necessary for this membrane interaction. Unirradiated leukaemic cells could show variable effects, depending upon secretion of CSA or possible inhibitors, possible favourable alterations in the CSA molecule, and the release of enzymes that could break down this favourably altered CSA. Because of the favourable effects of leukaemic addition to agar culture, inhibition may not be detected until enough leukaemic cells are added to secrete significant amounts of inhibitors. Obviously, the interactions of leukaemic cells with CFU-C are far from understood and require much more investigation. Lastly, it may not even occur at the level of the myeloid CFU-C, but at earlier stages in haemopoiesis. These results may therefore merely represent interesting in vitro findings.
